Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080259 · ClinicalTrials.gov registry record · NA
Primary Care Prevention of Stimulant Diversion by High School Students With ADHD
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 357
- Enrollment target
NCT03080259 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 357 participants.
The verdict
NCT03080259, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 357 participants
- Enrollment target
Study Summary
The purpose of this study is to test clinical strategies that pediatric providers may use to prevent misuse and diversion of stimulants by their adolescent patients with ADHD.
Interventions
- BEHAVIORAL Stimulant Diversion Prevention (SDP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2016-10-13 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03080259
The ClinicalTrials.gov registry entry for NCT03080259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 357 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stimulant Diversion Prevention (SDP) is the first listed.
NCT03080259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03080259 about?
NCT03080259 is a clinical study titled "Primary Care Prevention of Stimulant Diversion by High School Students With ADHD". The purpose of this study is to test clinical strategies that pediatric providers may use to prevent misuse and diversion of stimulants by their adolescent patients with ADHD.
What is the current status of trial NCT03080259?
This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2016-10-13. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03080259?
The interventions under investigation include: Stimulant Diversion Prevention (SDP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03080259?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.